1. Home
  2. IMMP vs WSBF Comparison

IMMP vs WSBF Comparison

Compare IMMP & WSBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • WSBF
  • Stock Information
  • Founded
  • IMMP 1987
  • WSBF 1921
  • Country
  • IMMP Australia
  • WSBF United States
  • Employees
  • IMMP N/A
  • WSBF N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • WSBF Savings Institutions
  • Sector
  • IMMP Health Care
  • WSBF Finance
  • Exchange
  • IMMP Nasdaq
  • WSBF Nasdaq
  • Market Cap
  • IMMP 304.0M
  • WSBF 296.4M
  • IPO Year
  • IMMP N/A
  • WSBF N/A
  • Fundamental
  • Price
  • IMMP $1.93
  • WSBF $13.20
  • Analyst Decision
  • IMMP Buy
  • WSBF
  • Analyst Count
  • IMMP 2
  • WSBF 0
  • Target Price
  • IMMP $8.50
  • WSBF N/A
  • AVG Volume (30 Days)
  • IMMP 98.7K
  • WSBF 58.6K
  • Earning Date
  • IMMP 02-27-2025
  • WSBF 01-28-2025
  • Dividend Yield
  • IMMP N/A
  • WSBF 4.54%
  • EPS Growth
  • IMMP N/A
  • WSBF 40.34
  • EPS
  • IMMP N/A
  • WSBF 0.71
  • Revenue
  • IMMP $2,563,302.00
  • WSBF $133,232,000.00
  • Revenue This Year
  • IMMP N/A
  • WSBF N/A
  • Revenue Next Year
  • IMMP $47.79
  • WSBF N/A
  • P/E Ratio
  • IMMP N/A
  • WSBF $18.68
  • Revenue Growth
  • IMMP 9.59
  • WSBF N/A
  • 52 Week Low
  • IMMP $1.66
  • WSBF $10.60
  • 52 Week High
  • IMMP $3.34
  • WSBF $16.86
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 42.28
  • WSBF 45.02
  • Support Level
  • IMMP $2.00
  • WSBF $11.95
  • Resistance Level
  • IMMP $2.05
  • WSBF $13.14
  • Average True Range (ATR)
  • IMMP 0.09
  • WSBF 0.34
  • MACD
  • IMMP -0.02
  • WSBF 0.07
  • Stochastic Oscillator
  • IMMP 8.33
  • WSBF 72.25

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About WSBF Waterstone Financial Inc. (MD)

Waterstone Financial Inc is a holding company. Through its subsidiaries, It operates in two segments: Community Banking and Mortgage Banking. The community banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the community banking segment.

Share on Social Networks: